Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis by Lotte C. Terpstra, Josje Altenburg, Inez Bronsveld, Martijn D. de Kruif, Yvonne Berk, Dominic Snijders, Wouter Rozemeijer, Harry G. M. Heijerman, Wim G. Boersma

Get full text

Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation by Marcella Burghard, Tim Takken, Merel M. Nap-van der Vlist, Sanne L. Nijhof, C. Kors van der Ent, Harry G.M. Heijerman, H.J. Erik Hulzebos

Get full text

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with... by Danya Muilwijk, Tessa J. van Paridon, Doris C. van der Heijden, Brenda M. Faber-Bisschop, Domenique D. Zomer-van Ommen, Harry G.M. Heijerman, Cornelis K. van der Ent

Get full text

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study by Johanna P. van Gemert, Bart Luijk, Merel E. Hellemons, Klara A. Visser, Carina.M.E. Hansen, Renske van der Meer, C. Tji Gan, Hester van der Vaart, Onno W. Akkerman, Willie N. Steenhuis, Marieke Verkleij, Harry G.M. Heijerman, Erik A.M. Verschuuren

Get full text